Tuesday, February 04, 2020 9:12:15 PM
That’s only 10days ago. It was fantastic news.
We asked the company for clarification on the patents. We just got that. Great to be getting feedback from them.
Austrianova needs to issue the paperwork.
It needs to be incorporated into the ind.
They need to do all proof reading and maybe some adjustments.
Facet needs to slot us into their schedule to get everything done.
Do they need to raise the funds to submit it?
I don’t think a few weeks is too long for all of that.
Let’s relax and let them do their jobs.
Why aren’t they giving us a date? Probably because they can’t be sure when it’s going to be completed and if they give a date and miss it we’ll all be on their backs and the share price will go down. So it’s good they don’t do that. What they expect and how long it will be are different things.
They did what they said they’d do with the manufacturing runs and tests.
They were successful. They kept at it and brought new expertise and did run after run until it was perfect.
That’s what they’ll do with the ind too.
If it takes another month it’s fine. Better to be perfect than flawed.
I have every faith in them to successfully submit the ind when it’s ready too.
No amount of fear or panicking is going to make that faster.
Just like the manufacturing runs, they will be careful diligent, scientific and legalistic in their preparation of the ind. they’re not going to rush it at this stage and maybe cause greater delays later.
The tests results were real. Independent. Exactly how the cells need to grow and trigger the ifosfamide.
They were successful despite our impatience, fears and doubts. There was nothing ‘mythical’ about it.
The ind submission will be just as successful.
They’ve only had final results for ten days. Ten days.
This is a novel and unique cancer therapy from a tiny biotech. It’s going to inject live human cells from a human into other humans. They need to submit the most thorough, carefully thought out, perfect application to be able to get the fda to let them do that.
And they need to impress them with their professionalism, care and thoroughness.
And they need to impress dr Hidalgo and the many clinics And doctors who will conduct the trials as well.
This is medicine. This is peoples lives. This is the fda.
This isn’t a pump n dump scam.
Recent PMCB News
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/13/2024 04:19:35 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 08/13/2024 08:37:40 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 07/29/2024 08:05:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:59:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/17/2024 08:58:35 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:05:04 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/30/2024 08:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:40:20 PM
- PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease • Business Wire • 05/21/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM